Keeping Track: UCB’s Very Good Day, Pfizer’s Great Year
Pfizer adds Velsipity and Penbraya to its US FDA novel approval haul and UCB’s Bimzelx finally achieves FDA clearance, along with Zilbrysq.
Pfizer adds Velsipity and Penbraya to its US FDA novel approval haul and UCB’s Bimzelx finally achieves FDA clearance, along with Zilbrysq.